주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
121 )
기사목록 보기 형태
제목형
요약형
포토형
How should the government reimburse Covid-19 treatments without harming patients?
Kim Yun-mi
2023.11.27 16:09
Will Piqray end up as ill-fated breast cancer drug in Korea?
Kim Yun-mi
2023.11.24 13:31
What impact will Keytruda have on treating advanced gastric cancer?
Kim Yun-mi
2023.11.14 18:15
Atopic dermatitis drug Adtralza passes insurance panel at ultrafast speed
Kim Yun-mi
2023.11.10 13:03
Why Korean gastric cancer research is recognized worldwide
Kim Yun-mi
2023.11.09 13:46
Patients upset over repeated failures to reimburse blood cancer drugs
Kim Yun-mi
2023.11.06 13:41
Handok paves the way for a smooth introduction of its new cancer drug
Kim Yun-mi
2023.11.02 13:49
2 new JAK inhibitors, Jyseleca and Jakavi, get insurance benefits this month
Kim Yun-mi
2023.11.01 11:32
Yuhan's Leclaza aims to enter US market based on MARIPOSA study’s success
Kim Yun-mi
2023.10.30 11:44
SGLT-2i Jardiance expands indication to treat chronic kidney disease
Kim Yun-mi
2023.10.26 15:24
Bladder cancer’s 1st-line treatment sees rapid change amid heaps of clinical translation challenges
Kim Yun-mi
2023.10.25 13:37
'Polivy' transforms 1st-line treatment for DLBCL after 20 years
Kim Yun-mi
2023.10.23 16:20
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기